Cargando…

Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients

PURPOSE: In patients with chronic obstructive pulmonary disease (COPD), bronchial responsiveness after acute administration of short acting bronchodilators is conventionally assessed by measuring the improvement of forced expiratory volume in the first second (FEV(1)) during a maximal forced expirat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pini, Laura, Ziletti, Giulia Claudia, Ciarfaglia, Manuela, Giordani, Jordan, Tantucci, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360132/
https://www.ncbi.nlm.nih.gov/pubmed/35851429
http://dx.doi.org/10.1007/s00408-022-00556-9
_version_ 1784764285855989760
author Pini, Laura
Ziletti, Giulia Claudia
Ciarfaglia, Manuela
Giordani, Jordan
Tantucci, Claudio
author_facet Pini, Laura
Ziletti, Giulia Claudia
Ciarfaglia, Manuela
Giordani, Jordan
Tantucci, Claudio
author_sort Pini, Laura
collection PubMed
description PURPOSE: In patients with chronic obstructive pulmonary disease (COPD), bronchial responsiveness after acute administration of short acting bronchodilators is conventionally assessed by measuring the improvement of forced expiratory volume in the first second (FEV(1)) during a maximal forced expiratory maneuver. This study aimed to measure the variation of intrathoracic airway wall compliance (AWC) after acute administration of short acting beta-2 agonist in COPD patients since this might influence the final modification of airway caliber during maximal expiratory effort and the resulting bronchodilation as inferred by FEV(1) changes. METHODS: In a group of 10 patients suffering from COPD, intrathoracic AWC was measured at middle (50% of Forced Vital Capacity (FVC) and low (75% of FVC) lung volumes using the interrupter method during forced expiratory maneuver in basal conditions and after acute inhalation of albuterol (salbutamol) (400 mcg by MDI). Ten healthy subjects were examined similarly as a control group. RESULTS: Lower values of baseline intrathoracic AWC at both lung volumes were found in COPD patients (1.72 ± 0.20 ml/cmH(2)O and 1.08 ± 0.20 ml/cmH(2)O, respectively) as compared to controls (2.28 ± 0.27 ml/cmH(2)O and 1.44 ± 0.22 ml/cmH(2)O, respectively) (p < 0.001). In COPD patients, AWC increased significantly at both lung volumes after salbutamol, amounting to 1.81 ± 0.38 ml/cmH(2)O and 1.31 ± 0.39 ml/cmH(2)O, respectively (p < 0.01), but the relative change was not different from that observed in controls. CONCLUSION: In COPD patients, AWC is reduced compared to controls, but after bronchodilator, the intrathoracic airways become more compliant. The consequent increased collapsibility under high positive pleural pressure could limit the airway caliber improvement seen after bronchodilator, as assessed by the FEV(1) changes during the forced expiratory maneuver, underestimating the effective bronchodilation achieved in these patients.
format Online
Article
Text
id pubmed-9360132
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-93601322022-08-10 Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients Pini, Laura Ziletti, Giulia Claudia Ciarfaglia, Manuela Giordani, Jordan Tantucci, Claudio Lung COPD PURPOSE: In patients with chronic obstructive pulmonary disease (COPD), bronchial responsiveness after acute administration of short acting bronchodilators is conventionally assessed by measuring the improvement of forced expiratory volume in the first second (FEV(1)) during a maximal forced expiratory maneuver. This study aimed to measure the variation of intrathoracic airway wall compliance (AWC) after acute administration of short acting beta-2 agonist in COPD patients since this might influence the final modification of airway caliber during maximal expiratory effort and the resulting bronchodilation as inferred by FEV(1) changes. METHODS: In a group of 10 patients suffering from COPD, intrathoracic AWC was measured at middle (50% of Forced Vital Capacity (FVC) and low (75% of FVC) lung volumes using the interrupter method during forced expiratory maneuver in basal conditions and after acute inhalation of albuterol (salbutamol) (400 mcg by MDI). Ten healthy subjects were examined similarly as a control group. RESULTS: Lower values of baseline intrathoracic AWC at both lung volumes were found in COPD patients (1.72 ± 0.20 ml/cmH(2)O and 1.08 ± 0.20 ml/cmH(2)O, respectively) as compared to controls (2.28 ± 0.27 ml/cmH(2)O and 1.44 ± 0.22 ml/cmH(2)O, respectively) (p < 0.001). In COPD patients, AWC increased significantly at both lung volumes after salbutamol, amounting to 1.81 ± 0.38 ml/cmH(2)O and 1.31 ± 0.39 ml/cmH(2)O, respectively (p < 0.01), but the relative change was not different from that observed in controls. CONCLUSION: In COPD patients, AWC is reduced compared to controls, but after bronchodilator, the intrathoracic airways become more compliant. The consequent increased collapsibility under high positive pleural pressure could limit the airway caliber improvement seen after bronchodilator, as assessed by the FEV(1) changes during the forced expiratory maneuver, underestimating the effective bronchodilation achieved in these patients. Springer US 2022-07-18 2022 /pmc/articles/PMC9360132/ /pubmed/35851429 http://dx.doi.org/10.1007/s00408-022-00556-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle COPD
Pini, Laura
Ziletti, Giulia Claudia
Ciarfaglia, Manuela
Giordani, Jordan
Tantucci, Claudio
Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients
title Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients
title_full Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients
title_fullStr Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients
title_full_unstemmed Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients
title_short Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients
title_sort acute effect of bronchodilator on intrathoracic airway wall compliance in copd patients
topic COPD
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360132/
https://www.ncbi.nlm.nih.gov/pubmed/35851429
http://dx.doi.org/10.1007/s00408-022-00556-9
work_keys_str_mv AT pinilaura acuteeffectofbronchodilatoronintrathoracicairwaywallcomplianceincopdpatients
AT zilettigiuliaclaudia acuteeffectofbronchodilatoronintrathoracicairwaywallcomplianceincopdpatients
AT ciarfagliamanuela acuteeffectofbronchodilatoronintrathoracicairwaywallcomplianceincopdpatients
AT giordanijordan acuteeffectofbronchodilatoronintrathoracicairwaywallcomplianceincopdpatients
AT tantucciclaudio acuteeffectofbronchodilatoronintrathoracicairwaywallcomplianceincopdpatients